United States Precision Medicine Market 2017 Analysis by Applications :Oncology, Neurosciences, Immunology, Respiratory, Others
According to the National Institutes of Health (NIH), Precision Medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Scope of the Report:
This report focuses on the Precision Medicine in United States market, to split the market based on manufacturers, states, type and application.
Request a sample copy of Precision Medicine Market Report @ https://www.bharatbook.com/request-sample/942567
Market Segment by Manufacturers, this report covers
- Johnson & Johnson
- GE Healthcare
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific
- Abbott Laboratories
- Almac Group
- Intel Corporation
- Biomrieux Sa
- Randox Laboratories
Market Segment by States, covering
- New York
Market Segment by Type, covers
Market Segment by Applications, can be divided into
To read the complete report, click the link: https://www.bharatbook.com/healthcare-market-research-reports-942567/united-states-precision-medicine.html
There are 17 Chapters to deeply display the United States Precision Medicine market.
Chapter 1, to describe Precision Medicine Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Precision Medicine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Precision Medicine, for each state, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;
Chapter 12, Precision Medicine market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 15, to describe sales channel, distributors, traders, dealers etc.
Chapter 16 and 17, to describe Precision Medicine Research Findings and Conclusion, Appendix, methodology and data source.
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Follow us on : Twitter, Facebook, Linkedin, Google Plus
**Disclaimer:The news, reports, views and opinions expressed by the Crowdfunding Platforms that are advertised at crweworld.com are their own and do not necessarily represent the views of CRWE World. Crown Equity Holdings Inc. has received $2,000.00 (two thousand dollars) in cash for 30 days of advertisement services for ChoiceTrade Holdings from Wallstreet Equities Ltd.